Press Releases

All Releases
View Summary Ironwood Pharmaceuticals to Present Clinical and Preclinical Data on sGC Stimulators at Upcoming Scientific Conferences
Mar 30, 2016
PDF 283.8 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Initiates Phase IIb Clinical Trial of IW-3718 in Refractory Gastroesophageal Reflux Disease
Mar 23, 2016
PDF 16.4 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Barclays Global Healthcare Conference
Mar 9, 2016
PDF 12.6 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Cowen and Company 36th Annual Health Care Conference
Mar 1, 2016
PDF 12.7 KB Add to Briefcase
View Summary Video Alert: Updated 2016 Direct-to-Consumer Awareness Campaign Available for LINZESS® (linaclotide)
Feb 29, 2016
PDF 12.3 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Announces Filing by Astellas of New Drug Application in Japan with Linaclotide for the Treatment of Adults with IBS-C
Feb 24, 2016
PDF 283.1 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2015 Investor Update
Feb 18, 2016
PDF 99.8 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Progresses Vascular and Fibrotic Disease Platform with Positive Top-Line Phase Ia Data on Soluble Guanylate Cyclase Stimulator IW-1701
Feb 18, 2016
PDF 283.7 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at 2016 RBC Capital Markets Global Healthcare Conference
Feb 17, 2016
PDF 12.5 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Host Fourth Quarter and Full-Year 2015 Investor Update Call
Feb 4, 2016
PDF 12.9 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Details Strategy to Build Top-Performing Commercial Biotechnology Company
Jan 11, 2016
PDF 107.0 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Jan 4, 2016
PDF 12.6 KB Add to Briefcase
View Summary Astellas and Ironwood Report Positive Top-Line Data from Phase III IBS-C Trial Conducted in Japan
Nov 30, 2015
PDF 115.4 KB Add to Briefcase
View Summary Ironwood Reports Positive Top-Line Data from Phase II Trial of Linaclotide in Adult Patients With Opioid-Induced Constipation
Nov 30, 2015
PDF 157.6 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Credit Suisse 24th Annual Healthcare Conference
Nov 4, 2015
PDF 15.6 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Provides Third Quarter 2015 Investor Update
Nov 3, 2015
PDF 187.2 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Initiates Clinical Studies of Soluble Guanylate Cyclase Stimulators IW-1973 and IW-1701
Nov 3, 2015
PDF 19.4 KB Add to Briefcase
View Summary Ironwood and Allergan Initiate Phase IIb Clinical Trial of Linaclotide Colonic Release in Adults with Irritable Bowel Syndrome with Constipation
Nov 2, 2015
PDF 160.8 KB Add to Briefcase
View Summary Allergan Acquires Rights To Ironwood's CONSTELLA® (Linaclotide) From Almirall In More Than 40 Countries
Oct 27, 2015
PDF 23.4 KB Add to Briefcase
View Summary Ironwood Highlights Refractory GERD and Constipation Research at the American College of Gastroenterology 2015 Annual Scientific Meeting
Oct 19, 2015
PDF 158.5 KB Add to Briefcase
Showing 41-60 of 228 Page: 1 2 3 4 5 6 7 ... 12  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase
You are now leaving ironwoodpharma.com. This link will take you to
a website to which our privacy policy does not apply. You are solely
responsible for your interactions with that website.